Mechanism of action of N7-methylguanosine in hepatocellular carcinoma
10.3969/j.issn.1001-5256.2023.12.029
- VernacularTitle:N7-甲基鸟苷（m7G）在肝细胞癌中的作用机制
- Author:
Chun GAO
1
;
Jingjing JIANG
2
;
Yuchun CHEN
2
;
Xiaohui YU
2
;
Jiucong ZHANG
2
;
3
Author Information
1. The First Clinical Medical College of Gansu University of Chinese Medicine， Lanzhou 730000， China
2. Department of Gastroenterology， The 940 Hospital of Joint Logistic Support Force of PLA， Lanzhou 730050， China
3. Department of Gastroenterology， The Second Hospital of Lanzhou University， Lanzhou 730030， China
- Publication Type:Review
- Keywords:
Carcinoma， Hepatocellular;
N7-methylguanosine;
Methylation
- From:
Journal of Clinical Hepatology
2023;39(12):2946-2951
- CountryChina
- Language:Chinese
-
Abstract:
N7-methylguanosine （m7G） is one of the most popular RNA modifications at present and has attracted wide attention from researchers in China and globally. By influencing the metabolism of various RNA molecules （including messenger RNA， ribosomal RNA， microRNA， and transfer RNA）， m7G modification actively participates in many biological processes such as cell proliferation， differentiation， and apoptosis. More and more evidence has shown that m7G plays a key role in the development of cancer， and abnormal m7G levels are closely associated with the development and progression of cancer by regulating the expression of multiple oncogenes and tumor suppressor genes. Hepatocellular carcinoma is the most common gastrointestinal tumor in China， and current treatment methods tend to have an unsatisfactory therapeutic effect. At present， the potential molecular mechanism of m7G modification in hepatocellular carcinoma remains unclear. This article reviews the potential mechanism of action of m7G modification in hepatocellular carcinoma and the m7G-related diagnosis and treatment strategies.
